NHIA_AnnualConference_24_White

Executive Preconference

An IRA Update for Home and Alternate Site Infusion Providers

The Part D benefit redesign portion of the Inflation Reduction Act (IRA) will begin in 2024 and fully implemented in 2025. This session will review the IRA provisions that affect infusion providers including an update on the drug price negotiations, copay caps, and how the Medicare Transaction Facilitator could impact cash flow.
The Part D benefit redesign portion of the Inflation Reduction Act (IRA) will begin in 2024 and fully implemented in 2025. This session will review the IRA provisions that affect infusion providers including an update on the drug price negotiations, copay caps, and how the Medicare Transaction Facilitator could impact cash flow.

Learning Objectives

  • Identify the portions of Part D benefit redesign taking effect in 2024.
  • Review how the Medicare Transaction Facilitator could impact organizational cash flow.
  • Learn the latest on IRA updates related to drug price negotiations, copay caps, and more.
  • Speaker(s)

    Bill Noyes 
    SVP of Reimbursement Policy
    NHIA

    Logan Davis PharmD, MBA
    Vice President of Trade
    Vital Care® Infusion Services

    Speaker
    Speaker

    Share:

    Registration for the Executive Preconference Required